DK1809750T3 - Selection of host cells expressing protein at high levels - Google Patents

Selection of host cells expressing protein at high levels

Info

Publication number
DK1809750T3
DK1809750T3 DK05810935.6T DK05810935T DK1809750T3 DK 1809750 T3 DK1809750 T3 DK 1809750T3 DK 05810935 T DK05810935 T DK 05810935T DK 1809750 T3 DK1809750 T3 DK 1809750T3
Authority
DK
Denmark
Prior art keywords
polypeptide
interest
host cells
selectable marker
cells expressing
Prior art date
Application number
DK05810935.6T
Other languages
Danish (da)
Inventor
Arie Pieter Otte
Blokland Henricus Johannes Maria Van
Theodorus Hendrikus Jacobus Kwaks
Richard George Antonius Bernardus Sewalt
Original Assignee
Chromagenics Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chromagenics Bv filed Critical Chromagenics Bv
Priority claimed from PCT/EP2005/055794 external-priority patent/WO2006048459A2/en
Application granted granted Critical
Publication of DK1809750T3 publication Critical patent/DK1809750T3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The invention provides a DNA molecule comprising a multicistronic transcription unit coding for i) a selectable marker polypeptide functional in a eukaryotic host cell, and for ii) a polypeptide of interest, the polypeptide of interest having a translation initiation sequence separate from that of the selectable marker polypeptide, characterized in that the coding sequence for the polypeptide of interest is downstream from the coding sequence for the selectable marker in the multicistronic transcription unit, and the nucleic acid sequence coding for the selectable marker polypeptide comprises a mutation that decreases the translation efficiency of the selectable marker in a eukaryotic host cell. The invention also provides methods for obtaining host cells expressing a polypeptide of interest, the host cells comprising the DNA molecules of the invention. The invention further provides the production of polypeptides of interest, comprising culturing host cells comprising the DNA molecules according to the invention.
DK05810935.6T 2004-11-08 2005-11-07 Selection of host cells expressing protein at high levels DK1809750T3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62630104P 2004-11-08 2004-11-08
EP04105593 2004-11-08
US69661005P 2005-07-05 2005-07-05
PCT/EP2005/055794 WO2006048459A2 (en) 2004-11-08 2005-11-07 Selection of host cells expressing protein at high levels

Publications (1)

Publication Number Publication Date
DK1809750T3 true DK1809750T3 (en) 2012-06-25

Family

ID=34929819

Family Applications (1)

Application Number Title Priority Date Filing Date
DK05810935.6T DK1809750T3 (en) 2004-11-08 2005-11-07 Selection of host cells expressing protein at high levels

Country Status (8)

Country Link
US (3) US20060172382A1 (en)
CN (1) CN101090968B (en)
AT (1) ATE550432T1 (en)
DK (1) DK1809750T3 (en)
ES (1) ES2384391T3 (en)
NZ (1) NZ553700A (en)
SI (1) SI1809750T1 (en)
ZA (1) ZA200702046B (en)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1573058T3 (en) * 2002-12-18 2012-01-16 Chromagenics Bv Process for improving protein production
WO2004056986A2 (en) * 2002-12-20 2004-07-08 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
SI1809750T1 (en) 2004-11-08 2012-08-31 Chromagenics Bv Selection of host cells expressing protein at high levels
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
BRPI0517380A (en) * 2004-11-08 2008-10-07 Chromagenics Bv DNA molecule, expression cassette, host cell, and methods for generating a host cell expressing a polypeptide of interest and for producing a polypeptide of interest
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
US20060195935A1 (en) 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
EP1820856B1 (en) * 2004-11-18 2011-04-27 National University of Corporation Hiroshima University Method and kit for expressing protein under regulation of the expression from repeated sequence formed by gene amplification and transformant
CN101389763B (en) * 2006-02-21 2013-01-23 科罗迈吉尼科斯公司 Selection of host cells expressing protein at high levels
PT2064337E (en) * 2006-09-20 2012-07-26 Genzyme Corp A facs-and reporter protein-based system for high throughput development of therapeutic proteins
JP5648912B2 (en) * 2008-02-27 2015-01-07 国立大学法人北海道大学 Expression vector for mass production of foreign gene-derived protein using animal cells, and use thereof
US9284563B2 (en) * 2009-06-15 2016-03-15 Cellagenics B.V. Stringent selectable markers
CN102648285A (en) 2009-08-06 2012-08-22 Cmc依科斯生技制品公司 Methods for improving recombinant protein expression
EP2611915B1 (en) 2010-09-01 2015-04-15 Cellagenics B.V. Nucleic acid fragments from a ribosomal protein promoter for enhancing gene expression
US20140243234A1 (en) * 2011-08-03 2014-08-28 Texas Biomedical Research Institute Nucleic acid compositions, methods and kits for rapid pairing of affinity agents
TWI698240B (en) 2012-05-15 2020-07-11 澳大利亞商艾佛蘭屈澳洲私營有限公司 Treatment of amd using aav sflt-1
EP3119798B1 (en) 2014-03-17 2020-08-05 Adverum Biotechnologies, Inc. Compositions and methods for enhanced gene expression in cone cells
CN104531699B (en) * 2014-10-09 2017-03-15 河南农业大学 A kind of UCOE controlling element fragments of the pig for strengthening exogenous gene expression
KR20170137730A (en) 2015-03-02 2017-12-13 애드베룸 바이오테크놀로지스, 인코포레이티드 Composition and method for intravitreal delivery of polynucleotides to retinal cones
IL258537B2 (en) 2015-10-09 2024-05-01 Genzyme Corp Improved flare (flow cytometry attenuated reporter expression) technology for rapid bulk sorting
GB2545763A (en) 2015-12-23 2017-06-28 Adverum Biotechnologies Inc Mutant viral capsid libraries and related systems and methods
WO2018067964A1 (en) 2016-10-07 2018-04-12 Genzyme Corporation Early post-transfection isolation of cells (epic) for biologics production
US20220193266A1 (en) * 2019-04-30 2022-06-23 Chan Zuckerberg Biohub, Inc. A novel chromatin-opening element for stable long term gene expression
CN110484563B (en) * 2019-07-25 2023-04-07 新乡医学院 Mammal cell combined expression vector, expression system, preparation method and application
EP4247947A1 (en) 2020-11-19 2023-09-27 Genzyme Corporation Flow cytometry attenuated reporter expression (flare) multiple reporter system and methods of use thereof

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965196A (en) * 1983-01-19 1990-10-23 Genentech, Inc. Polycistronic expression vector construction
FR2569723B1 (en) * 1984-08-31 1986-09-19 Centre Nat Rech Scient APPLICATION OF ANTIBIOTICS FROM THE PHLEOMYCIN FAMILY AS A SELECTION AGENT IN THE FIELD OF GENETIC ENGINEERING
CA2063799A1 (en) 1989-07-24 1991-01-25 Frank S. Genbauffe Prevention of internal initiation
ATE199023T1 (en) 1991-03-29 2001-02-15 Genentech Inc METHODS FOR SELECTING RECOMBINANT HOST CELLS WHICH EXPRESS HIGH AMOUNTS OF A DESIRED PROTEIN
US6319707B1 (en) * 1991-08-12 2001-11-20 Fred Hutchinson Cancer Research Center Board Regents Of The University Of Washington Cap-independent multicistronic retroviral vectors
JP2686025B2 (en) * 1992-08-25 1997-12-08 理化学研究所 Blasticidin S deaminase gene
DE4228458A1 (en) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronic expression units and their use
ES2088838T3 (en) * 1992-11-13 2004-01-01 Idec Pharmaceuticals Corporation FULLY ALTERED KOZAK CONSENSUS SEQUENCES INTENDED FOR EXPRESSION IN THE MAMMALS.
US5648267A (en) * 1992-11-13 1997-07-15 Idec Pharmaceuticals Corporation Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same
AU6498294A (en) 1993-04-07 1994-10-24 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Dna sequence which acts as a chromatin insulator element to protect expressed genes from (cis)-acting regulatory sequences in mammalian cells
US5610053A (en) * 1993-04-07 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services DNA sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells
US5658763A (en) * 1993-10-25 1997-08-19 Creative Biomolecules, Inc. Methods and compositions for high protein production from non-native DNA
US5972605A (en) * 1994-07-07 1999-10-26 Geron Corporation Assays for regulators of mammalian telomerase expression
US5561053A (en) * 1994-08-05 1996-10-01 Genentech, Inc. Method for selecting high-expressing host cells
WO1996012008A1 (en) 1994-10-13 1996-04-25 Merck & Co., Inc. Synthesis of methylase-resistant genes
US5627033A (en) 1995-03-28 1997-05-06 Research & Diagnostics Systems, Inc. Mammalian expression vectors
PT1445322E (en) * 1995-06-15 2010-01-19 Crucell Holland Bv Packaging systems for human recombinant adenovirus to be used in gene therapy
US5773695A (en) * 1996-01-26 1998-06-30 North Carolina State University Plant nuclear scaffold attachment region and method for increasing gene expression in transgenic cells
US6107477A (en) * 1996-09-26 2000-08-22 Aurora Biosciences Corporation Non-optimal Kozaks sequences
US5773779A (en) * 1997-02-21 1998-06-30 The Lincoln Electric Company Method and system for welding railroad rails
WO1998039411A1 (en) 1997-03-04 1998-09-11 Baxter International Inc. Adenovirus e1-complementing cell lines
US5888809A (en) 1997-05-01 1999-03-30 Icos Corporation Hamster EF-1α transcriptional regulatory DNA
US6689606B2 (en) * 1998-07-21 2004-02-10 M.L. Laboratories Plc Polynucleotide
AU771111B2 (en) 1998-07-21 2004-03-11 Emd Millipore Corporation A polynucleotide comprising a ubiquitous chromatin opening element (UCOE)
ATE370247T1 (en) * 1998-08-14 2007-09-15 Chromagenics Bv DNA SEQUENCE, METHOD FOR DETECTION AND PRODUCTION THEREOF AND USE THEREOF
US6800457B2 (en) * 1998-09-22 2004-10-05 Bristol-Myers Squibb Company Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
US6521419B1 (en) * 1998-09-22 2003-02-18 Kanakaraju Koduri Expression vectors containing hot spot for increased recombinant protein expression in transfected cells
WO2000023606A1 (en) 1998-10-22 2000-04-27 Medical College Of Georgia Institute, Inc. Long terminal repeat, enhancer, and insulator sequences for use in recombinant vectors
AU776752B2 (en) 1999-06-30 2004-09-23 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The DNA binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression
DE60031419T2 (en) * 1999-08-25 2007-09-27 Immunex Corp., Thousand Oaks COMPOSITIONS AND METHODS FOR IMPROVED CELL CULTURE
CA2389633A1 (en) 1999-11-01 2001-05-10 Chiron Corporation Expression vectors, transfection systems, and method of use thereof
US6558948B1 (en) * 1999-11-23 2003-05-06 Stefan Kochanek Permanent amniocytic cell line, its production and use for the production of gene transfer vectors
AU2001243142A1 (en) 2000-02-03 2001-08-14 Hyseq, Inc. Novel nucleic acids and polypeptides
US6586205B1 (en) * 2000-02-11 2003-07-01 Millennium Pharmaceuticals, Inc. 43239 a novel GPCR-like molecule and uses thereof
US20030166042A1 (en) * 2000-02-11 2003-09-04 Millennium Pharmaceuticals, Inc. Novel seven-transmembrane proteins/G-protein coupled receptors
KR100996016B1 (en) 2000-09-20 2010-11-22 밀리포어 코포레이션 Polynucleotide
JP4307079B2 (en) 2001-01-26 2009-08-05 セレキス エスアー Matrix attachment region and method of use
US20020155540A1 (en) * 2001-02-14 2002-10-24 Malla Padidam Method to reduce transcriptional interference between tandem genes
WO2002068627A2 (en) * 2001-02-23 2002-09-06 Novartis Ag Vector constucts
FR2821855B1 (en) 2001-03-09 2004-04-02 Cayla SYNTHETIC GENES AND BACTERIAL PLASMIDS WITHOUT GIC
TWI377253B (en) * 2001-04-16 2012-11-21 Martek Biosciences Corp Product and process for transformation of thraustochytriales microorganisms
US20040161817A1 (en) 2001-06-04 2004-08-19 Corixa Corporation Compositions and methods for high-level, large-scale production of recombinant proteins
DK1829971T3 (en) * 2001-07-04 2010-08-16 Chromagenics Bv DNA sequences with anti-repressor activity
EP1273666A1 (en) 2001-07-04 2003-01-08 Chromagenics B.V. Method of selecting a DNA sequence with transcription modulating activity using a vector comprising an element with a gene transcription repressing activity
ITMI20012110A1 (en) * 2001-10-12 2003-04-12 Keryos Spa MULTI-CISTRONIC VECTORS USABLE IN GENE TRANSFER PROTOCOLS
US20040038304A1 (en) 2002-03-28 2004-02-26 Gala Design, Inc. Antibody libraries
AU2003243059A1 (en) * 2002-06-14 2003-12-31 Chromagenics B.V. Use of repression blocking sequences in methods for enhancing gene expression
AU2003238719B2 (en) * 2002-06-14 2008-02-21 Chromagenics B.V. A method for simultaneous production of multiple proteins, vectors and cells for use therein
US7344886B2 (en) * 2002-11-29 2008-03-18 Boehringer Ingelheim Pharma Gmbh & Co., Kg Neomycin-phosphotransferase-genes and methods for the selection of recombinant cells producing high levels of a desired gene product
DK1573058T3 (en) * 2002-12-18 2012-01-16 Chromagenics Bv Process for improving protein production
WO2004056986A2 (en) 2002-12-20 2004-07-08 Chromagenics B.V. Means and methods for producing a protein through chromatin openers that are capable of rendering chromatin more accessible to transcription factors
US7153659B2 (en) * 2003-09-05 2006-12-26 Genencor International, Inc. HPV CD8+ T-cell epitopes
EA011747B1 (en) * 2004-07-08 2009-06-30 Хромагеникс Б.В. A recombinant nucleic acid molecule having anti-repressor activity, and methods for use thereof
US20100136616A1 (en) * 2004-11-08 2010-06-03 Chromagenics B.V. Selection of Host Cells Expressing Protein at High Levels
US8999667B2 (en) * 2004-11-08 2015-04-07 Chromagenics B.V. Selection of host cells expressing protein at high levels
SI1809750T1 (en) * 2004-11-08 2012-08-31 Chromagenics Bv Selection of host cells expressing protein at high levels
US20060195935A1 (en) * 2004-11-08 2006-08-31 Chromagenics B.V. Selection of host cells expressing protein at high levels
BRPI0517380A (en) * 2004-11-08 2008-10-07 Chromagenics Bv DNA molecule, expression cassette, host cell, and methods for generating a host cell expressing a polypeptide of interest and for producing a polypeptide of interest
US8039230B2 (en) * 2004-11-08 2011-10-18 Chromagenics B.V. Selection of host cells expressing protein at high levels
US7968700B2 (en) * 2006-03-20 2011-06-28 Chromagenics B.V. Expression augmenting DNA fragments, use thereof, and methods for finding thereof
JP5501054B2 (en) 2010-03-25 2014-05-21 株式会社トクヤマ Method for producing 3,3-diaminoacrylic acid (1-diphenylmethylazetidin-3-yl) ester acetate

Also Published As

Publication number Publication date
SI1809750T1 (en) 2012-08-31
US20060172382A1 (en) 2006-08-03
ZA200702046B (en) 2008-09-25
US20140186890A1 (en) 2014-07-03
US8771984B2 (en) 2014-07-08
US20110014655A1 (en) 2011-01-20
NZ553700A (en) 2010-09-30
CN101090968B (en) 2011-10-26
CN101090968A (en) 2007-12-19
ATE550432T1 (en) 2012-04-15
ES2384391T3 (en) 2012-07-04

Similar Documents

Publication Publication Date Title
DK1809750T3 (en) Selection of host cells expressing protein at high levels
WO2006048459A3 (en) Selection of host cells expressing protein at high levels
DK2013349T3 (en) Selection of host cells expressing protein at high levels
WO2002029088A3 (en) Highly expressible genes
BRPI0515264A (en) multimeric builders
ATE510920T1 (en) DNA SEQUENCES FOR REGULATION OF TRANSCRIPTION
ATE521695T1 (en) CIRCULAR DNA MOLECULE HAVING A CONDITIONAL REPLICATION ORIGIN, METHOD FOR PRODUCING THEREOF AND THEIR USE IN GENE THERAPY
WO2003038049A3 (en) Method for isolating cell-type specific mrnas
RU2008134484A (en) NEW FLUORESCENT PROTEINS AND WAYS OF THEIR APPLICATION
EP1841871A4 (en) Novel l-lysine-inducible promoter
MX2019009045A (en) Novel luciferases and methods for using same.
JP2008505626A5 (en)
DE60333032D1 (en) SCREENING METHOD FOR IDENTIFYING EFFECTIVE PRE-TRANS SPRAYING MOLECULES
WO2003074706A1 (en) PROTEIN OR POLYPEPTIDE HAVING LACHRYMATOR SYNTHASE ACTIVITY, DNA ENCODING THE PROTEIN OR THE POLYPEPTIDE, PROCESS FOR PRODUCING PROTEIN OR POLYPEPTIDE HAVING LACHRYMATOR SYNTHASE ACTIVITY USING THE DNA, AND NUCLEIC ACID MOLECULE INHIBITING THE TRANSLATION OF mRNA CONCERNING THE PROTEIN OR THE PEPTIDE
ATE463572T1 (en) RECOMBINANT FACTOR VIII WITH INCREASED SPECIFIC ACTIVITY
Shin et al. Targeted genome editing using DNA-free RNA-guided Cas9 ribonucleoprotein for CHO cell engineering
WO2006097945A3 (en) A method for achieving high-level expression of recombinant human interleukin-2 upon destabilization of the rna secondary structure
EA200702009A1 (en) IMPROVED METHOD OF EXPRESSING CLONING IN HOST CELL
WO2003104426A3 (en) Isolated nucleic acid molecule encoding a novel centromere-associated motor protein, and uses thereof
WO2006023956A3 (en) Method for gene transfer into the organelles of cells: direct gene transfer to mitochondria
ATE440956T1 (en) VECTORS CONTAINING NEW REGULATORY ELEMENTS
Lyngaard et al. Physcomitrella HMGA-type proteins display structural differences compared to their higher plant counterparts
AR049129A1 (en) NUCLEIC ACID MOLECULES THAT CODIFY CYCLETID POLYPEPTIDES AND METHODS OF THE SAME USE
DE602006019486D1 (en) MATERIALS AND METHOD FOR INCREASING THE PEPTIDE CHAIN EXPRESSION
NZ603077A (en) Biological materials and uses thereof